Get 40% Off
These stocks are up over 10% post earnings. Did you spot the buying opportunity? Our AI did.Read how

Teva Pharmaceutical To Rally Around 58%? Here Are 10 Top Analyst Forecasts For Monday

Published 12/02/2024, 12:43
Updated 12/02/2024, 14:10
© Reuters.  Teva Pharmaceutical To Rally Around 58%? Here Are 10 Top Analyst Forecasts For Monday

Benzinga - by Avi Kapoor, Benzinga Staff Writer.

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.

  • UBS raised the price target for Urban Outfitters, Inc. (NASDAQ: URBN) from $21 to $41. UBS analyst Jay Sole upgraded the stock from Sell to Neutral. Urban Outfitters shares gained 2.2% to close at $42.53 on Friday. See how other analysts view this stock.
  • Goldman Sachs boosted United Therapeutics Corporation (NASDAQ: UTHR) price target from $213 to $215. Goldman Sachs analyst Chris Shibutani upgraded the stock from Sell to Neutral. United Therapeutics shares rose 0.3% to close at $212.34 on Friday. See how other analysts view this stock.
  • Deutsche Bank boosted the price target for Mohawk Industries, Inc. (NYSE: MHK) from $98 to $152. Deutsche Bank analyst Joe Ahlersmeyer upgraded the stock from Hold to Buy. Mohawk Industries shares gained 0.4% to close at $110.01 on Friday. See how other analysts view this stock.
  • Keybanc raised NerdWallet, Inc. (NASDAQ: NRDS) price target from $18 to $20. Keybanc analyst Justin Patterson maintained an Overweight rating. NerdWallet shares rose 2% to close at $15.52 on Friday. See how other analysts view this stock.
  • Piper Sandler boosted the price target for Teva Pharmaceutical Industries Limited (NYSE: TEVA) from $12 to $19. Piper Sandler analyst David Amsellem upgraded the stock from Neutral to Overweight. Teva Pharmaceutical shares fell 0.7% to close at $12.01 on Friday. See how other analysts view this stock.
  • Keefe, Bruyette & Woods raised the price target for Assurant, Inc. (NYSE: AIZ) from $170 to $182. Keefe, Bruyette & Woods analyst Thomas McJoynt-Griffith downgraded the stock from Outperform to Market Perform. Assurant shares fell 0.1% to close at $174.49 on Friday. See how other analysts view this stock.
  • Stifel increased Viavi Solutions Inc. (NASDAQ: VIAV) price target from $10 to $13. Stifel analyst Ruben Roy upgraded the stock from Hold to Buy. Viavi Solutions shares gained 2.4% to close at $8.91 on Friday. See how other analysts view this stock.
  • Barclays cut Rivian Automotive, Inc. (NASDAQ: RIVN) price target from $25 to $16. Barclays analyst Dan Levy downgraded the stock from Overweight to Equal-Weight. Rivian Automotive shares gained 3.5% to close at $16.68 on Friday. See how other analysts view this stock.
  • Baird raised Construction Partners, Inc. (NASDAQ: ROAD) price target from $46 to $50. Baird analyst Andrew Wittmann downgraded the stock from Outperform to Neutral. Construction Partners shares fell 7% to close at $46.81 on Friday. See how other analysts view this stock.
  • Morgan Stanley boosted XPO, Inc. (NYSE: XPO) price target from $75 to $80. Morgan Stanley analyst Ravi Shanker downgraded the stock from Equal-Weight to Underweight. XPO shares gained 2.4% to close at $120.84 on Friday. See how other analysts view this stock.
3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Check This Out: Waste Management, Goodyear Tire And 3 Stocks To Watch Heading Into Monday

© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Read the original article on Benzinga

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.